MATINAS BIOPHARMA HOLDINGS, INC.
Asset & Liabilities Breakdown
Asset Breakdown FY2022
Total Assets: $44.8M
Liabilities Breakdown FY2022
Total Liabilities: $8.2M
Asset Breakdown
Total Assets: $44.8M
| Line Item | Value | % of Total |
|---|---|---|
| Cash & Equivalents | $6.8M | 15.2% |
| Accounts Receivable | $0 | 0.0% |
| Inventory | $0 | 0.0% |
| Property, Plant & Equipment | $2.1M | 4.7% |
| Goodwill | $1.3M | 3.0% |
| Intangible Assets | $3.0M | 6.7% |
| Other Assets | $31.5M | 70.4% |
Liabilities Breakdown
Total Liabilities: $8.2M
| Line Item | Value | % of Total |
|---|---|---|
| Accounts Payable | $618.0K | 7.6% |
| Long-Term Debt | $0 | 0.0% |
| Other Liabilities | $7.6M | 92.4% |